In June 2018, the APCP Neurodisability (ND) Group conducted a survey of physiotherapists, primarily paediatric/APCP members, who inject Botulinum Toxin-A for Management of Focal Spasticity in Children. An annual survey to assess APCP member’s learning needs and to support their development is part of our 5 year work plan. For 2018, the ND group decided to look at an area of Advanced Practice.
The survey was sent to all APCP members with an invitation to share the survey with any other therapists they knew to be injecting within a paediatric setting. The survey was open for 4 weeks with a reminder message sent after 2 weeks.